Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
Aon
AON
|
+$1.04B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$901M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$823M |
| 5 |
Pinduoduo
PDD
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Datadog
DDOG
|
+$747M |
| 3 |
TSMC
TSM
|
+$707M |
| 4 |
Baxter International
BAX
|
+$703M |
| 5 |
Estee Lauder
EL
|
+$592M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.28% |
| 2 | Healthcare | 10.85% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Nautilus Biotechnolgy
NAUT
$115M
| $1.15M | ﹤0.01% |
414,182
+42,568
| +11% | +$89.3K |
|
|
AMPS
4652
DELISTED
Altus Power
AMPS
| $1.15M | ﹤0.01% |
209,342
+61,863
| +42% | +$434K |
|
|
GLOP
4653
DELISTED
GASLOG PARTNERS LP
GLOP
| $1.14M | ﹤0.01% |
135,884
+54,967
| +68% | +$444K |
|
4654
Oppenheimer Holdings
OPY
$1.2B
| $1.14M | ﹤0.01% |
29,099
+3,713
| +15% | +$163K |
|
4655
VanEck Uranium + Nuclear Energy ETF
NLR
$4.17B
| $1.14M | ﹤0.01% |
20,457
-193
| -0.9% | -$10.8K |
|
4656
LCNB Corp
LCNB
$283M
| $1.13M | ﹤0.01% |
69,446
+12,546
| +22% | +$223K |
|
4657
CS Disco
LAW
$279M
| $1.13M | ﹤0.01% |
170,541
-4,614
| -3% | -$32.8K |
|
4658
SelectQuote
SLQT
$121M
| $1.13M | ﹤0.01% |
521,532
+242,103
| +87% | +$391K |
|
4659
RBB Bancorp
RBB
$455M
| $1.13M | ﹤0.01% |
72,830
+36,530
| +101% | +$699K |
|
4660
GeoPark
GPRK
$612M
| $1.13M | ﹤0.01% |
99,288
+4,501
| +5% | +$59.8K |
|
4661
Perella Weinberg Partners
PWP
$1.3B
| $1.13M | ﹤0.01% |
123,913
+17,218
| +16% | +$172K |
|
4662
Aemetis
AMTX
$124M
| $1.13M | ﹤0.01% |
485,054
-32,889
| -6% | -$123K |
|
4663
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.93B
| $1.12M | ﹤0.01% |
50,000
+45,651
| +1,050% | +$1.02M |
|
|
IGMS
4664
DELISTED
IGM Biosciences
IGMS
| $1.12M | ﹤0.01% |
81,684
-10,053
| -11% | -$208K |
|
|
PNT
4665
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.12M | ﹤0.01% |
153,616
+107,946
| +236% | +$801K |
|
4666
Organogenesis Holdings
ORGO
$239M
| $1.12M | ﹤0.01% |
524,019
-1,455,098
| -74% | -$3.59M |
|
4667
Ouster
OUST
$2.92B
| $1.12M | ﹤0.01% |
133,297
+11,639
| +10% | +$135K |
|
|
ATXS
4668
DELISTED
Astria Therapeutics
ATXS
| $1.12M | ﹤0.01% |
83,849
+64,024
| +323% | +$866K |
|
|
SPPP
4669
Sprott Physical Platinum and Palladium Trust
SPPP
$621M
| $1.11M | ﹤0.01% |
90,942
-753
| -0.8% | -$9.49K |
|
4670
Virtus Terranova US Quality Momentum ETF
JOET
$249M
| $1.11M | ﹤0.01% |
40,263
+40,233
| +134,110% | +$1.1M |
|
4671
Teucrium Wheat Fund
WEAT
$292M
| $1.11M | ﹤0.01% |
31,372
+21,317
| +212% | +$787K |
|
4672
Seres Therapeutics
MCRB
$48.9M
| $1.1M | ﹤0.01% |
9,711
-1,235
| -11% | -$134K |
|
4673
Donegal Group Class A
DGICA
$714M
| $1.1M | ﹤0.01% |
71,991
+4,601
| +7% | +$69.2K |
|
|
TARO
4674
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.1M | ﹤0.01% |
45,175
+953
| +2% | +$27.8K |
|
4675
Babcock & Wilcox
BW
$1.39B
| $1.09M | ﹤0.01% |
180,165
+116,193
| +182% | +$717K |
|
Similar funds
Morgan Stanley's Q1 2023 Portfolio in Review
As of Q1 2023, Morgan Stanley held 8,043 positions worth $933B, up 5.9% from $880B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2023 filing shows 163 new, 3,525 increased, 3,121 reduced and 300 closed positions. Its largest new stake was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2023 buy was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.62B increase.
- Morgan Stanley's biggest Q1 2023 reduction was Apple, cutting an estimated $1.19B.
- Morgan Stanley fully exited SVB Financial Group in Q1 2023, selling an estimated $354M.
- Morgan Stanley's ten largest holdings make up 16% of its $933B portfolio in Q1 2023.
- Morgan Stanley opened 163 new positions and closed 300 in Q1 2023.
- Morgan Stanley's portfolio value rose 5.9% quarter-over-quarter to $933B.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.